ModiQuest Research, a leading custom antibody generation and development company, will be attending the Protein engineering summit this May 1-5 in Boston. Immunized animals are still a key source of antibodies generated within therapeutic campaigns to obtain high affinity antibody drug candidates. Therefore, humanization and de-risking of these antibodies is an important antibody engineering step … Continue reading